Chapter 3 Part 2 Flashcards
Histamine
Source: mast cells, basophils, platelets
Action: vasodilation, increased vascular permeability, endothelial activation
Prostaglandins
Source: mast cells, leukocytes
Action: vasodilation, pain, fever
Leukotrienes
Source: mast cells, leukocytes
Action: increased vascular permeability, chemotaxis, leukocyte adhesion, and activation
Cytokines (TNF, IL-6, IL-1)
Source: macrophages, endothelial cells, mast cells
Local Action: endothelial activation (expression of adhesion molecules)
Systemic Action: fever, metabolic abnormalities, hypotension (shock)
Chemokines
Source: leukocytes, activated macrophages
Action: chemotaxis, leukocyte activation
Platelet-activating Factor
Source: leukocytes, mast cells
Action: vasodilation, increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst
Complement
Source: plasma (produced in liver)
Action: leukocyte chemotaxis and activation, fireteams target killing (membrane attack complex), vasodilation (mast cell stimulation)
Kinins
Source: plasma (produced in liver)
Action: increased vascular permeability, smooth muscle contraction, vasodilation, pain
What are the most important mediators of acute inflammation?
vasoactive amines, lipid products (prostaglandins and leukotrienes), cytokines (including chemokines), products of complement activation
Cell-derived mediators
sequestered in intracellular granules and can be rapidly secreted by granule exocytosis or are synthesized de novo
ex) histamine in mast cell granules
Major cell types that produce mediators of acute inflammation
macrophages, dendritic cells, mast cells
Plasma-derived mediators
produced mainly in the liver and are present in circulation as inactive precursors that must be activated
ex) complement proteins
2 major vasoactive amines
histamine
serotonin
Histamine: storage, release, and action
Storage: mast cell granules
Release: mast cell degranulation in response to 1) physical injury; 2) binding of antibodies to mast cell; 3) products of complement (C3a and C5a); 4) neuropeptides, cytokine (IL-1, IL-8)
Action: dilation of arterioles and increased permeability of venules via H1 receptor binding
Serotonin: storage, release, action
Storage: preformed in platelets and neuroendocrine cells
Action: neurotransmitter in GI tract, vasoconstrictor
What two lipid mediators are produced from Arachidonic Acid?
Prostaglandins
Leukotrienes
What is AA made of?
20-carbon unsaturated fatty acid from diet or essential fatty acid linoleum acid esterified in membrane phospholipids
Release of AA
mechanical, chemical, physical mediators release AA from membrane phospholipids via action of phospholipase A2
What two major classes of enzymes do eicosanoids (AA-derived mediators) synthesize?
Cyclooxygenases: generate prostaglandins
Lipoxygenases: produce leukotrienes and lipoxins
What do steroids inhibit?
phospholipase (inhibit release of AA)
What do COX-1 and COX-2 inhibitors, aspirin, and indomethacin inhibit?
cyclooxygenase (production of prostaglandins)
Prostacyclin PGI2 action
vasodilation, inhibits platelet aggregation
Thromboxane A2 (TXA2) action
vasoconstriction, promotes platelet aggregation
PGD2, PGE2 actions
vasodilation, increased vascular permeability
5-HETE action
chemotaxis
Leukotriene C4, D4, E4 (LTC4, LTD4, LTE4) actions
bronchospasm, increased vascular permeability
Lipoxin A4, B4 (LXA4, LXB4) actions
inhibition of inflammation
What do leukotriene receptor antagonists inhibit?
bronchospasm produced by LTC4, LTD4, LTE4
Which eicosanoids cause vasodilation?
Prostaglandins PGI2, PGE1, PGE2, PGD2
Which eicosanoids cause vasocontriction?
Thromboxane A2, Leukotrienes C4, D4, E4